The significant binding of Ikaros to the promoter of BCL6 and BACH2 was confirmed by qChIP in both Nalm6 cells (Figure 3C) and primary cells from ALL patients (Figure 3D). Here, BACH2 is linked to acute lymphoblastic leukemia.